Home

Heritage Foundation View: Medicare Drug Proposals

Tue, 06/20/2000 - 11:00pm — Karen Stevenson
Description: 

A new paper by the Heritage Foundation examines three bills before Congress which would affect drug coverage and prices. The International Prescription Drug Parity Act (H.R. 1885/S. 1191) would allow wholesalers to import in bulk any prescription drug approved by the Food and Drug Administration. The Prescription Drug Fairness Act (S. 2464) would prohibit U.S. drug manufacturers from selling products to foreign buyers for less than they charge domestic buyers. The Medicare Prescription Drug Plan (S. 2319) would permit seniors to enroll in a new Medicare drug benefit program if they agree to combine their Part A and Part B deductibles. They conclude that all three bills fall short of providing a comprehensive solution to the problems older people face.

A new paper by the Heritage Foundation examines three bills before Congress which would affect drug coverage and prices. The International Prescription Drug Parity Act (H.R. 1885/S. 1191) would allow wholesalers to import in bulk any prescription drug approved by the Food and Drug Administration. The Prescription Drug Fairness Act (S. 2464) would prohibit U.S. drug manufacturers from selling products to foreign buyers for less than they charge domestic buyers. The Medicare Prescription Drug Plan (S. 2319) would permit seniors to enroll in a new Medicare drug benefit program if they agree to combine their Part A and Part B deductibles. They conclude that all three bills fall short of providing a comprehensive solution to the problems older people face.